Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma

Mengjun Wang, Jiabin Shen, Harmin Herrera, Amit Singal, Charles Swindell, Lu Renquan, Anand Mehta

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) accounts for >700,000 deaths worldwide, largely related to poor rates of diagnosis. Our previous work identified glycoproteins with increased levels of fucosylation in HCC. Plate-based assays to measure this change were compromised by increased levels of heterophilic antibodies with glycan lacking terminal galactose residues, which allowed for increased binding to the lectins used in these assays. To address this issue, we developed a multi-step protein A/G incubation and filtration method to remove the contaminating signal. However, this method was time consuming and expensive so alternative methods were desired. Herein, we describe a simple method relying on PEG precipitation that allows for the removal of IgG and IgM but retention of glycoproteins of interest. This method was tested on three sample sets, two internal and one external. PEG depletion of heterophilic IgG and IgM reduced in the coefficient of variation as observed with the protein A/G filtration method from 26.82% to 7.50% and allowed for the measurement of fucosylated protein. This method allowed for the measurement of fucosylated kininogen, which could serve as a biomarker of HCC. In conclusion, a new and simple method for the depletion of heterophilic IgG and IgM was developed and allowed for the analysis of fucosylated kininogen in patients with liver disease.

Original languageEnglish (US)
Pages (from-to)59-64
Number of pages6
JournalJournal of Immunological Methods
Volume462
DOIs
StatePublished - Nov 1 2018

Fingerprint

Kininogens
Lectins
Hepatocellular Carcinoma
Biomarkers
Antibodies
Immunoglobulin M
Immunoglobulin G
Staphylococcal Protein A
Glycoproteins
Galactose
Polysaccharides
Liver Diseases

Keywords

  • Biomarker
  • Glycosylation
  • Hepatocellular carcinoma
  • Lectin, liver cance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma. / Wang, Mengjun; Shen, Jiabin; Herrera, Harmin; Singal, Amit; Swindell, Charles; Renquan, Lu; Mehta, Anand.

In: Journal of Immunological Methods, Vol. 462, 01.11.2018, p. 59-64.

Research output: Contribution to journalArticle

Wang, Mengjun ; Shen, Jiabin ; Herrera, Harmin ; Singal, Amit ; Swindell, Charles ; Renquan, Lu ; Mehta, Anand. / Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma. In: Journal of Immunological Methods. 2018 ; Vol. 462. pp. 59-64.
@article{5c066eb412d44400a13c345c90c3031a,
title = "Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) accounts for >700,000 deaths worldwide, largely related to poor rates of diagnosis. Our previous work identified glycoproteins with increased levels of fucosylation in HCC. Plate-based assays to measure this change were compromised by increased levels of heterophilic antibodies with glycan lacking terminal galactose residues, which allowed for increased binding to the lectins used in these assays. To address this issue, we developed a multi-step protein A/G incubation and filtration method to remove the contaminating signal. However, this method was time consuming and expensive so alternative methods were desired. Herein, we describe a simple method relying on PEG precipitation that allows for the removal of IgG and IgM but retention of glycoproteins of interest. This method was tested on three sample sets, two internal and one external. PEG depletion of heterophilic IgG and IgM reduced in the coefficient of variation as observed with the protein A/G filtration method from 26.82{\%} to 7.50{\%} and allowed for the measurement of fucosylated protein. This method allowed for the measurement of fucosylated kininogen, which could serve as a biomarker of HCC. In conclusion, a new and simple method for the depletion of heterophilic IgG and IgM was developed and allowed for the analysis of fucosylated kininogen in patients with liver disease.",
keywords = "Biomarker, Glycosylation, Hepatocellular carcinoma, Lectin, liver cance",
author = "Mengjun Wang and Jiabin Shen and Harmin Herrera and Amit Singal and Charles Swindell and Lu Renquan and Anand Mehta",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.jim.2018.08.010",
language = "English (US)",
volume = "462",
pages = "59--64",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",

}

TY - JOUR

T1 - Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma

AU - Wang, Mengjun

AU - Shen, Jiabin

AU - Herrera, Harmin

AU - Singal, Amit

AU - Swindell, Charles

AU - Renquan, Lu

AU - Mehta, Anand

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Hepatocellular carcinoma (HCC) accounts for >700,000 deaths worldwide, largely related to poor rates of diagnosis. Our previous work identified glycoproteins with increased levels of fucosylation in HCC. Plate-based assays to measure this change were compromised by increased levels of heterophilic antibodies with glycan lacking terminal galactose residues, which allowed for increased binding to the lectins used in these assays. To address this issue, we developed a multi-step protein A/G incubation and filtration method to remove the contaminating signal. However, this method was time consuming and expensive so alternative methods were desired. Herein, we describe a simple method relying on PEG precipitation that allows for the removal of IgG and IgM but retention of glycoproteins of interest. This method was tested on three sample sets, two internal and one external. PEG depletion of heterophilic IgG and IgM reduced in the coefficient of variation as observed with the protein A/G filtration method from 26.82% to 7.50% and allowed for the measurement of fucosylated protein. This method allowed for the measurement of fucosylated kininogen, which could serve as a biomarker of HCC. In conclusion, a new and simple method for the depletion of heterophilic IgG and IgM was developed and allowed for the analysis of fucosylated kininogen in patients with liver disease.

AB - Hepatocellular carcinoma (HCC) accounts for >700,000 deaths worldwide, largely related to poor rates of diagnosis. Our previous work identified glycoproteins with increased levels of fucosylation in HCC. Plate-based assays to measure this change were compromised by increased levels of heterophilic antibodies with glycan lacking terminal galactose residues, which allowed for increased binding to the lectins used in these assays. To address this issue, we developed a multi-step protein A/G incubation and filtration method to remove the contaminating signal. However, this method was time consuming and expensive so alternative methods were desired. Herein, we describe a simple method relying on PEG precipitation that allows for the removal of IgG and IgM but retention of glycoproteins of interest. This method was tested on three sample sets, two internal and one external. PEG depletion of heterophilic IgG and IgM reduced in the coefficient of variation as observed with the protein A/G filtration method from 26.82% to 7.50% and allowed for the measurement of fucosylated protein. This method allowed for the measurement of fucosylated kininogen, which could serve as a biomarker of HCC. In conclusion, a new and simple method for the depletion of heterophilic IgG and IgM was developed and allowed for the analysis of fucosylated kininogen in patients with liver disease.

KW - Biomarker

KW - Glycosylation

KW - Hepatocellular carcinoma

KW - Lectin, liver cance

UR - http://www.scopus.com/inward/record.url?scp=85054361680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054361680&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2018.08.010

DO - 10.1016/j.jim.2018.08.010

M3 - Article

C2 - 30144410

AN - SCOPUS:85054361680

VL - 462

SP - 59

EP - 64

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

ER -